119176-67-9
119176-67-9
Chemical Structure
Azelaic acid-d14
Synonym(s): Nonanedioic acid-d14
- CAS No.: 119176-67-9
- Formula:C9H2D14O4
- Molecular Weight:202.31
IUPAC Name: nonanedioic-d14 acid
InChIKey: BDJRBEYXGGNYIS-ODSOAMBASA-N
SMILES: OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(O)=O)=O
Biological Activity: Azelaic acid-d14 is the deuterium labeled Azelaic acid[1]. Azelaic acid is an organic compound produced by the ozonolysis of oleic acid;component of a number of hair and skin conditioners[2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Azelaic acid-d14 | 99.86% | Azelaic acid-d14 is the deuterium labeled Azelaic acid. Azelaic acid is an organic compound produced by the ozonolysis of oleic acid;component of a number of hair and skin conditioners. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Azelaic acid (Standard) | 99.80% | Azelaic acid (Standard) is the analytical standard of Azelaic acid. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Azelaic acid | 98.0% | Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Jung HW, et al. Priming in systemic plant immunity. Science. 2009 Apr 3;324(5923):89-91. [Content Brief]
- [3]. Liu RH, et al. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol. 2006 Aug142(8):1047-52. [Content Brief]
